Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation

Digestive and Liver Disease

Volumn 43, Issue 3, 2011, Pages 242-245

  Caraceni, Paolo ^a   Santi, Luca ^a   Mirici, Federica ^a   Montanari, Giancarlo ^a   Bevilacqua, Vittoria ^a   Pinna, Antonio Daniele ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Hepatorenal syndrome; Liver transplantation; Terlipressin

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; HUMAN ALBUMIN; MIDODRINE; OCTREOTIDE; TERLIPRESSIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BLEEDING; BUDD CHIARI SYNDROME; CASE REPORT; CREATININE BLOOD LEVEL; DIALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS; HEPATITIS C; HEPATORENAL SYNDROME; HERPES VIRUS INFECTION; HUMAN; HYPOVOLEMIC SHOCK; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; OLIGURIA; PARACENTESIS; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SPONTANEOUS BACTERIAL PERITONITIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT DURATION; VASOCONSTRICTION;

ADULT; AGED; ALBUMINS; CREATININE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEPATORENAL SYNDROME; HUMANS; LIVER TRANSPLANTATION; LYPRESSIN; MALE; MIDDLE AGED; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 79551481883     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.08.001     Document Type: Article

References (12)

1. Salerno F., Gerbes A., Gines P., et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310-1318.
2. Ginès P., Schrier R.W. Renal failure in cirrhosis. N Engl J Med 2009, 361:1279-1290.
3. Martìn-Llahì M., Pèpin M.N., Guevara M., et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008, 134:1352-1359.
4. Sanyal A.J., Boyer T., Garcia-Tsao G., et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008, 134:1360-1368.
5. Gluud L.L., Christensen K., Christensen E., et al. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010, 51:576-584.
6. Ganne-Carrie N., Hadengue A., Mathurin P., et al. Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci 1996, 41:1054-1056.
7. Mulkay J.P., Louis H., Donckier V., et al. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg 2001, 64:15-19.
8. Angeli P., Volpin R., Gerunda G., et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999, 29:1690-1697.
9. Nair S., Verma S., Thuluvath P.J. Pre-transplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002, 35:1179-1185.
10. Restuccia T., Ortega R., Guevara M., et al. Effects of treatment of hepatorenal syndrome before transplantation on post-transplantation outcome. A case-control study. J Hepatol 2004, 40:140-146.
11. Hadengue A., Moreau R., Gaudin C., et al. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 1992, 15:809-815.
12. Møller S., Bendtsen F., Henriksen J.H. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995, 109:1917-1925.